|
MLL5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.65039999841821E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.0351000057085E-09 |
| Normal-vs-Stage2 |
2.383300E-03 |
| Normal-vs-Stage3 |
1.540000E-03 |
| Normal-vs-Stage4 |
3.483700E-02 |
| Stage1-vs-Stage2 |
5.239800E-01 |
| Stage1-vs-Stage3 |
6.863100E-03 |
| Stage1-vs-Stage4 |
3.156700E-04 |
| Stage2-vs-Stage3 |
2.968000E-01 |
| Stage2-vs-Stage4 |
9.860300E-02 |
| Stage3-vs-Stage4 |
3.559800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.86840000138133E-08 |
| Normal-vs-AfricanAmerican |
2.140000E-01 |
| Normal-vs-Asian |
4.435900E-02 |
| Caucasian-vs-AfricanAmerican |
2.724300E-02 |
| Caucasian-vs-Asian |
4.587600E-02 |
| AfricanAmerican-vs-Asian |
1.818140E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.2141999996056E-07 |
| Normal-vs-Female |
2.15519999957614E-07 |
| Male-vs-Female |
4.363400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.862000E-02 |
| Normal-vs-Age(41-60Yrs) |
1.24400000300895E-08 |
| Normal-vs-Age(61-80Yrs) |
2.01489999999138E-05 |
| Normal-vs-Age(81-100Yrs) |
2.633000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.018400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.642200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.396600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.598000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.333230E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.887800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.409500E-04 |
| Normal-vs-Grade 2 |
4.73750039198251E-10 |
| Normal-vs-Grade 3 |
7.87819999999995E-05 |
| Normal-vs-Grade 4 |
1.439170E-01 |
| Grade 1-vs-Grade 2 |
1.182370E-01 |
| Grade 1-vs-Grade 3 |
4.677700E-03 |
| Grade 1-vs-Grade 4 |
5.406300E-04 |
| Grade 2-vs-Grade 3 |
5.776700E-03 |
| Grade 2-vs-Grade 4 |
1.622850E-04 |
| Grade 3-vs-Grade 4 |
8.104200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.63913327355658E-12 |
| Normal-vs-ccB subtype |
2.659000E-03 |
| ccA subtype-vs-ccB subtype |
2.54359999951603E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.52229999994535E-06 |
| Normal-vs-N1 |
1.788550E-01 |
| N0-vs-N1 |
3.888000E-01 |
|
|
